Taina Pajunen

Title: Taina Pajunen: Innovator in Pharmaceutical Compounds

Introduction

Taina Pajunen is a notable inventor based in Espoo, Finland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit catechol O-methyltransferase (COMT) activity. Her work has implications for various therapeutic applications.

Latest Patents

Taina Pajunen holds a patent for "Catechol O-methyltransferase activity inhibiting compounds." The compounds of formula (I), as defined in the claims, exhibit COMT enzyme inhibiting activity and are thus useful as COMT inhibitors. The patent also discloses methods of treatment and pharmaceutical dosage forms.

Career Highlights

Taina is associated with Orion Corporation, a prominent company in the pharmaceutical industry. Her innovative work has positioned her as a key figure in the development of new therapeutic agents.

Collaborations

Taina has collaborated with notable colleagues, including Marko Ahlmark and David Din Belle. These partnerships have enhanced her research and contributed to the advancement of her projects.

Conclusion

Taina Pajunen's contributions to pharmaceutical innovations, particularly in COMT inhibitors, highlight her role as a leading inventor in her field. Her work continues to pave the way for new treatment options.